Progress in Neurotherapeutics and Neuropsychopharmacology

Table of Contents - 2007 - Volume 2, Issue 01  

As this article doesn't contain an abstract, the image below is necessary to enable the article to be indexed by certain search engines. The resolution of the full-text PDF is much higher than that shown here.

Review Article

Pilot Clinical Trial of NT-3 in CMT1A Patients

Zarife Sahenk a1c1
a1 Department of Neurology and Pediatrics, The Ohio State University, Columbus Children's Research Institute, Neuromuscular program, Columbus, OH, USA; Email: sahenkz@ccri.net

Article author query
sahenk z   [PubMed][Google Scholar] 

Key Words: CMT disease; NT-3; regeneration; Schwann cell.

Correspondence:
c1 Corresopndence should be addressed to: Zarife Sahenk, MD, PhD, Department of Neurology and Pediatrics, The Ohio State University; Columbus Children's Research Institute, Neuromuscular program, Columbus, OH, USA; Tel; +614722 2202; Fax: +614 355 5247; Email: sahenkz@ccri.net